Here's the latest info shared by WHO's Adriana Velázquez regarding Medical Devices and the World Health Organization (June 2020 Edition).
Please find below information related to COVID-19 technical documents, for your consideration.
Please note the COVID website has changed (many documents are being developed), so the new links are available here.
1. Clinical Management of Patients (updated version)
2. Priority Medical Devices for COVID Management
WHO has developed several tools which can be found here.
The List of Priority Medical Devices for COVID describes critical medical devices, their purpose, and the settings where each can be used. You can find the list here.
3. Emergency Supply Catalogue
4. COVID-19 Essential Supplies Forecasting Tool
5. Medical Equipment to Treat COVID Patients, Including Oxygen Delivery Systems
(New) The WHO technical specifications for PSA Oxygen Plants publicly available here.
(New)The imaging diagnostics roles are available here.
6. For Personal Protective Equipment
(New) Use of masks in the community during homecare and in healthcare settings in the context of the novel coronavirus (2019 ncov) outbreak guide is available here.
Rational use of personal protective equipment for coronavirus disease (COVID-19): this document summarizes WHO’s recommendations for the rational use of personal protective equipment (PPE) in health care and home care settings, as well as during the handling of cargo; it also assesses the current disruption of the global supply chain and considerations for decision making during severe shortages of PPE. This updated version includes a section on considerations for decision-making processes and a summary of temporary measures in the context of severe PPE shortage. Access the publication here.
7. For In Vitro Diagnostics
Laboratory testing guidance available here.
Advice on the use of point of care immunodiagnostic tests for COVID-19 available here.
WHO Emergency Use Listing (EUL) for in vitro diagnostics: Currently, the following IVDs are eligible for EUL submission:
- Assays for the detection of SARS-CoV-2 nucleic acid
- Rapid diagnostic tests for the detection of IgM/IgG to SARS-CoV-2 ·
All information can be found here.
The EUL procedure is developed to expedite the availability of IVDs needed in public health emergency situations. It is intended to assist interested procurement agencies and the Member States on the suitability for use of a specific IVD, based on a minimum set of available quality, safety, and performance data. More information can be found here.
8. For SARI Treatment Centers
9. For Manufacturers
WHO is conducting a high-level market and risk assessment for respiratory equipment. Please participate by answering the survey here.
10. On Innovation
If you have an innovative product (approved for emergency use, or commercially available), that might help COVID, please complete the WHO SURVEY here so that your product could be assessed for COVID-19 compendia.
Related past compendia of innovative technologies can be found here.
Other sites of interest for innovation, some will provide grants for development or :
- Bill and Melinda Gates Foundation information
- Unitaid’s Executive Board today approved up to US$ 30 million for work against COVID-19, authorizing Unitaid to contribute its expertise in innovative treatment, diagnostics, and respiratory triage tools to the global pandemic response.
- Global innovations exchange
- Grand Challenges Canada
- UN Innovation network
- Innovation call Islamic Development Bank
11. Very Important Country Data Surveys
Biomedical Equipment Inventory Tool for COVID-19.
In the context of COVID-19, availability of essential equipment to provide oxygen and respiratory therapy to all countries, especially those that may have limitations in accessing global markets, is of utmost importance.
WHO has developed a COVID-19 Biomedical Equipment Inventory Tool (survey) whose aim is to collect facility data on the availability of biomedical equipment (oxygen, accessories, and consumables) and ventilators at the country level. This data can serve to inform planning and readiness, at facilities and in-country, as well as to inform WHO’s global COVID-19 Supply Chain System of existing capacity so that appropriate equipment gets sent to where it can be absorbed, and in an equitable manner.
- WHO Biomedical Equipment Inventory Tool. Quick start guide
- Biomedical Equipment for COVID-19 Case Management Interim guidance. Inventory tool for facility readiness and equipment re-allocation. 06 May 2020 docx, 2.54Mb
- PDF version (06 May 2020) pdf, 1.19Mb ·
- 20200506_WHO_2020_Covid19_BioEquip_open.xlsx xlsx, 105kb
The survey can be accessed through a web browser by clicking this link.
Update of the Global Atlas Country Data
12. Severe Acute Respiratory Infections Treatment Centre
Practical manual to set up and manage SARI treatment center and a SARI screening. Access the publication here.
13. Global Accelerator to Increase Access to Diagnostics, Vaccines, and Treatment
PLEASE STAY SAFE!!
Adriana Velazquez Berumen, MSc. | Biomedical Engineer | Group Lead Medical Devices and In Vitro Diagnostics, MDD | Health Product Policy and Standards Department, HPS | Access to Medicines and Health Products Division, MHP | World Health Organization, Geneva, Switzerland